Ambis # 1674112 recombinant human thrombopoietin, CF 5 X 100UG. (5 X $566.00 = $2,830.00.) CAT. # 288-TP/CF / quote no. QT30432.

Ended Awarded Last action

Contract number
HHSN27200086
Awardee
Awarding agency
Obligated
$7,770

Award facts

Contract value 14% obligated
  • $7,770.00 Current, with exercised options
  • $54,630.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Minneapolis, MN 55413, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 1 -$120
Original award $7,890

Quick answers

Who was awarded contract HHSN27200086?

HHSN27200086 was awarded to Research And Diagnostic Systems, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on March 28, 2014.

How much is contract HHSN27200086 worth?

The government has obligated $7,770 on HHSN27200086. Its potential value, with all options, is $54,630.

Is contract HHSN27200086 an order under another contract?

Yes. HHSN27200086 is a BPA call under HHSN263199900050140B, a blanket purchase agreement.

Was contract HHSN27200086 competed?

The extent of competition for HHSN27200086 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award